Ivor Royston Email

CEO and President . Viracta Therapeutics (formerly Sunesis)

Cardiff-by-the-Sea, CA

Location

Current Roles

Employees:
52
Revenue:
$5.9M
About
Viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr Virus, and will pursue opportunities to address other serious virus-associated disease.
Viracta Therapeutics (formerly Sunesis) Address
2533 S. Coast Hwy 101
Cardiff-by-the-Sea, CA
United States
Viracta Therapeutics (formerly Sunesis) Email
Viracta Therapeutics (formerly Sunesis) Phone Numbers
858-400-8470

Past Companies

Geneditor Biologics Corp.Executive Chairman
Viracta Therapeutics, Inc., a NASDAQ listed biotech company [VIRX]Non-executive Member Board of Directors
Viracta Therapeutics, Inc., a NASDAQ listed biotech company [VIRX]President, CEO, Founder, and Executive Board Member

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.